Viatris to Sell Biosimilars Business for $3 Billion. Shares Tumble.

Viatris will sell the biosimilars business of the former Mylan to the Indian drugmaker Biocon for as much as $3.3 billion.


Dreamstime

Text size

Source: https://www.barrons.com/articles/viatris-sell-biosimilars-business-for-3-billion-shares-51646068401?siteid=yhoof2&yptr=yahoo